Tracy Zimmermann
Fortune : - $ au 31/10/2026
Fortune : - $ au 31/10/2026
Tracy Zimmermann is Chief Scientific Officer at City Therapeutics, Inc. since 2024.
Formerly, Dr. Zimmermann was Chief Development Officer at Generation Bio Co. from 2020 to 2024 and Senior Director-Research at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Education includes undergraduate studies at Lehigh University and a doctorate from the University of Colorado Boulder.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 16/10/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Corporate Officer/Principal | 28/01/2024 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national